Outset Medical Inc. (OM)
NASDAQ (NGS) NASDAQ (NGS) Primary Summary
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Outset Medical (OM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Outset Medical Q2 Earnings Call Highlights
Outset Medical NASDAQ: OM reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare.
Outset Medical Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 175 | $805.66 | $913.5 | $107.84 | 13.39% |
| PER Paul E. Rasmussen SIT INVESTMENT ASSOCIATES Inc. | 177 | $1,988.76 | $853.14 | -$1,135.62 | -57.1% |
| NA Nizar Araji National Bank Of Canada /FI/ | 46,190.63 | $564,814.07 | $226,334.08 | -$338,479.99 | -59.93% |
| OZI Omar Z. Idilby GMT CAPITAL Corp. | 98,108 | $402,907.61 | $442,467.08 | $39,559.47 | 9.82% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 39 | $149.76 | $178.23 | $28.47 | 19.01% |
Outset Medical Inc. (OM) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Outset Medical Inc. ever had a stock split?
Outset Medical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Leslie L. Trigg CEO | NASDAQ (NGS) Exchange | 690145206 CUSIP |
| US Country | 310 Employees | - Last Dividend | 20 Mar 2025 Last Split | 15 Sep 2020 IPO Date |
Overview
Outset Medical, Inc. is a medical technology firm focused on advancing the field of hemodialysis, currently servicing the United States. Originally named Home Dialysis Plus, Ltd., the company underwent a rebranding to Outset Medical, Inc. in January 2015, further reflecting its broadened vision and commitment to innovation in dialysis care. Established in 2003 and based in San Jose, California, Outset Medical has positioned itself at the forefront of the medical sector by developing the Tablo Hemodialysis System, a state-of-the-art solution designed to make dialysis care more accessible and efficient in both acute and home settings.
Products and Services
- Tablo Hemodialysis System
- Tablo Cartridge and Other Consumables
- Tablo Data Ecosystem
This flagship product by Outset Medical redefines dialysis treatment through its compact console, integrating water purification and on-demand dialysate production. Designed with user-friendliness and efficiency in mind, the Tablo System supports dialysis care needs in various settings, including hospitals and home environments. Equipped with advanced software and connectivity capabilities, it offers a comprehensive solution for modern dialysis treatment.
In addition to the main console, Outset Medical manufactures, supports, and distributes consumables such as the Tablo Cartridge. These consumables are critical components of the Tablo Hemodialysis System, ensuring the efficient operation of the dialysis process and maintaining the high-quality standards of care expected by patients and healthcare providers.
The Tablo Data Ecosystem enhances the Tablo Hemodialysis System's value by incorporating data analytics and connectivity tools. This ecosystem includes TabloHub, a customer-facing portal designed for healthcare professionals; MyTablo, a patient-facing portal that offers patients insights and control over their treatment; and TabloDash, an internal analytics platform that allows the company to monitor and optimize the use of the Tablo system across different environments. This holistic approach not only simplifies the management of dialysis care but also empowers all stakeholders with actionable insights.
